Literature DB >> 16437470

Combination contraceptives: effects on weight.

M F Gallo, L M Lopez, D A Grimes, K F Schulz, F M Helmerhorst.   

Abstract

BACKGROUND: Weight gain is often considered a side effect of combination hormonal contraceptives, and many women and clinicians believe that an association exists. Concern about weight gain can limit the use of this highly effective method of contraception by deterring the initiation of its use and causing early discontinuation among users. However, a causal relationship between combination contraceptives and weight gain has not been established.
OBJECTIVES: The aim of the review was to evaluate the potential association between combination contraceptive use and changes in weight. SEARCH STRATEGY: We searched the computerized databases MEDLINE, POPLINE, CENTRAL, EMBASE, and LILACS for studies of combination contraceptives. We also wrote to known investigators and manufacturers to request information about other published or unpublished trials not discovered in our search. SELECTION CRITERIA: All English-language, randomized controlled trials were eligible if they had at least three treatment cycles and compared a combination contraceptive to a placebo or to a combination contraceptive that differed in drug, dosage, regimen, and/or study length. DATA COLLECTION AND ANALYSIS: All titles and abstracts located in the literature searches were assessed. Data were entered and analyzed with RevMan, and a second author verified the data entered. Depending on the data available, the weighted mean difference using a fixed effects model with 95% confidence intervals (CI) was calculated for the mean change in weight between baseline and post-treatment measurements or the Peto odds ratio with 95% confidence intervals was calculated using the proportion of women who gained or lost more than a specified amount of weight. MAIN
RESULTS: The three placebo-controlled, randomized trials did not find evidence supporting a causal association between combination oral contraceptives or a combination skin patch and weight gain. Most comparisons of different combination contraceptives showed no substantial difference in weight. In addition, discontinuation of combination contraceptives because of weight gain did not differ between groups where this was studied. AUTHORS'
CONCLUSIONS: Available evidence was insufficient to determine the effect of combination contraceptives on weight, but no large effect was evident.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16437470     DOI: 10.1002/14651858.CD003987.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  6 in total

1.  User satisfaction with the combined oral contraceptive drospirenone 3 mg/ethinylestradiol 20 microg (Yasminelle) in clinical practice: a multi-country, questionnaire-based study.

Authors:  Mary Short
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 2.  Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling.

Authors:  William A Fisher; Amanda Black
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

3.  Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women.

Authors:  Kelli Stidham Hall; Katharine O'Connell White; Vaughn I Rickert; Nancy Reame; Carolyn Westhoff
Journal:  Contraception       Date:  2012-06-04       Impact factor: 3.375

4.  Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.

Authors:  Lianne Parkin; Katrina Sharples; Rohini K Hernandez; Susan S Jick
Journal:  BMJ       Date:  2011-04-21

5.  Effect of the ethinylestradiol/norelgestromin contraceptive patch on body composition. Results of bioelectrical impedance analysis in a population of Italian women.

Authors:  Antonio Piccoli; PierGiorgio Crosignani; Carmine Nappi; Salvatore Ronsini; Vincenzina Bruni; Silvia Marelli
Journal:  Nutr J       Date:  2008-08-26       Impact factor: 3.271

6.  Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review.

Authors:  Alessandra Graziottin
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.